相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2
M. Schlee et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Gastrointestinal microbiology enters the metagenomics era
Daniel N. Frank et al.
CURRENT OPINION IN GASTROENTEROLOGY (2008)
Predominance of a bacteriocin-producing Lactobacillus salivarius component of a five-strain probiotic in the porcine ileum and effects on host immune phenotype
Maria C. Walsh et al.
FEMS MICROBIOLOGY ECOLOGY (2008)
Microbial influences in inflammatory bowel diseases
R. Balfour Sartor
GASTROENTEROLOGY (2008)
Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial
Marc G. H. Besselink et al.
LANCET (2008)
The 10 remaining mysteries of inflammatory bowel disease
Jean-Frederic Colombel et al.
GUT (2008)
Review article: the evidence base for interventions used to maintain remission in Crohn's disease
A. K. Akobeng
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
Sya N. Ukena et al.
PLOS ONE (2007)
Problotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis
Julia Ewaschuk et al.
HEPATOLOGY (2007)
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
Daniel N. Frank et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Are probiotics detectable in human feces after oral uptake by healthy volunteers?
Martina Prilassnig et al.
WIENER KLINISCHE WOCHENSCHRIFT (2007)
High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease
Shunji Fujimori et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy -: A randomized, double-blind trial
Nada Rayes et al.
ANNALS OF SURGERY (2007)
Induction of human β-defensin 2 by the probiotic Escherichia coli nissle 1917 is mediated throuah flagellin
Miriam Schlee et al.
INFECTION AND IMMUNITY (2007)
Effects of the probiotic formulation VSL#3 on colitis in weanling rats
Leo R. Fitzpatrick et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)
Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair
Agata A. Zyrek et al.
CELLULAR MICROBIOLOGY (2007)
Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis
Meiling Zhang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Multicenter randomized-control led clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection
Andre Van Gossum et al.
INFLAMMATORY BOWEL DISEASES (2007)
Failure of synbiotic 2000 to prevent postoperative recurrence of Crohn's disease
Irit Chermesh et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Diversity of the human gastrointestinal tract microbiota revisited
Mirjana Rajilic-Stojanovic et al.
ENVIRONMENTAL MICROBIOLOGY (2007)
Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis
Martin Feller et al.
LANCET INFECTIOUS DISEASES (2007)
Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease
S. Zeissig et al.
GUT (2007)
Reduced mucosal antimicrobial activity in Crohn's disease of the colon
Sabine Nuding et al.
GUT (2007)
Maintenance of surgically induced remission of Crohn's disease
Florian Froehlich et al.
DIGESTION (2007)
Importance of microbial colonization of the gut in early life to the development of immunity
Denise Kelly et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2007)
Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and yersiniabactin in Escherichia coli strain Nissle 1917
Marianne Valdebenito et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis
Sandra Angulo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease
Pauline D. Scanlan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Inerences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis
Uri Gophna et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
A new ferrous iron-uptake transporter, EfeU (YcdN), from Escherichia coli
Cornelia Grosse et al.
MOLECULAR MICROBIOLOGY (2006)
The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients
Rodrigo Bibiloni et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Probiotic drug therapy with E. coli strain nissle 1917 (EcN):: Results of a prospective study of the records of 3807 patients
H. J. Krammer et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2006)
Validation of 16S rDNA sequencing in microdissected bowel biopsies from Crohn's disease patients to assess bacterial flora diversity
G. De Hertogh et al.
JOURNAL OF PATHOLOGY (2006)
Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways
A. Grabig et al.
INFECTION AND IMMUNITY (2006)
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease:: a randomised, double blind, placebo controlled GETAID trial
P. Marteau et al.
GUT (2006)
Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis
K Lucke et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach
C Manichanh et al.
GUT (2006)
NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2
E Voss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Oral administration of probiotic bacteria (E-coli Nissle, E-coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice
A. Kokesova et al.
FOLIA MICROBIOLOGICA (2006)
VSL#3 probiotic mixture - A review of its use in chronic inflammatory bowel diseases
Therese M. Chapman et al.
DRUGS (2006)
Reduced Paneth cell α-defensins in ileal Crohn's disease
J Wehkamp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Saccharomyces boulardii:: Basic science and clinical applications in gastroenterology
JP Buts et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2005)
A randomized, double-blind trial of lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease
A Bousvaros et al.
INFLAMMATORY BOWEL DISEASES (2005)
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis
R Bibiloni et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo
M Schultz et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2005)
Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data
JB Sun et al.
JOURNAL OF BIOTECHNOLOGY (2005)
Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis
A Kamada et al.
INFLAMMATORY BOWEL DISEASES (2005)
Inulin, oligofructose and immunomodulation
B Watzl et al.
BRITISH JOURNAL OF NUTRITION (2005)
Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling
A Sturm et al.
INFECTION AND IMMUNITY (2005)
Microbes, immunoregulation, and the gut
GAW Rook et al.
GUT (2005)
Transcriptional regulation through RfaH contributes to intestinal colonization by Escherichia coli
G Nagy et al.
FEMS MICROBIOLOGY LETTERS (2005)
CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation
F Obermeier et al.
GASTROENTEROLOGY (2005)
Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis:: a randomised controlled pilot trial
E Furrie et al.
GUT (2005)
Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases
JP Cannon et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - A randomized, double-blind trial
N Rayes et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens
A Altenhoefer et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2004)
Functional modulation of enterocytes by gram-positive and gram-negative microorganisms
JM Otte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Lactobacillus GG in inducing and maintaining remission of Crohn's disease
M Schultz et al.
BMC GASTROENTEROLOGY (2004)
Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis
D Rachmilewitz et al.
GASTROENTEROLOGY (2004)
Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917
L Grozdanov et al.
JOURNAL OF BACTERIOLOGY (2004)
The importance of butyrate transport to the regulation of gene expression in the colonic epithelium
MA Cuff et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis
K Kato et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression
J Wehkamp et al.
GUT (2004)
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis
T Mimura et al.
GUT (2004)
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
W Kruis et al.
GUT (2004)
NF-κB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917:: A novel effect of a probiotic bacterium
J Wehkamp et al.
INFECTION AND IMMUNITY (2004)
Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics
RB Sartor
GASTROENTEROLOGY (2004)
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease
SJ Ott et al.
GUT (2004)
The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN
SI Patzer et al.
MICROBIOLOGY-SGM (2003)
Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E-coli strains isolated from patients with Crohn's disease
J Boudeau et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance
J McCarthy et al.
GUT (2003)
A pilot trial of Saccharomyces boulardii in ulcerative colitis
M Guslandi et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2003)
Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial
P Gionchetti et al.
GASTROENTEROLOGY (2003)
Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment
LA Dieleman et al.
GUT (2003)
Host recognition of bacterial muramyl dipeptide mediated through NOD2
N Inohara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon
P Seksik et al.
GUT (2003)
Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora
J Kuisma et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis
H Ishikawa et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2003)
Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases
M Schultz et al.
DIGESTIVE DISEASES (2003)
Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples
G Blum-Oehler et al.
RESEARCH IN MICROBIOLOGY (2003)
Analysis of the intestinal microflora using molecular methods
GW Tannock
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2002)
Lactobacillus bacteremia during a rapid increase in Probiotic use of Lactobacillus rhamnosus GG in Finland
MK Salminen et al.
CLINICAL INFECTIOUS DISEASES (2002)
Increased mucosal tumour necrosis factor α production in Crohn's disease can be downregulated ex vivo by probiotic bacteria
N Borruel et al.
GUT (2002)
A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917
L Grozdanov et al.
JOURNAL OF BACTERIOLOGY (2002)
Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model
AF Mattar et al.
PEDIATRIC SURGERY INTERNATIONAL (2002)
Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease:: a randomised controlled trial with Lactobacillus GG
C Prantera et al.
GUT (2002)
Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis
A Oláh et al.
BRITISH JOURNAL OF SURGERY (2002)
Early enteral supply of lactobacillus and fiber versus selective bowel decontamination:: A controlled trial in liver transplant recipients
N Rayes et al.
TRANSPLANTATION (2002)
Human β-defensin 2 but not β-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease
J Wehkamp et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis
D Rachmilewitz et al.
GASTROENTEROLOGY (2002)
Mucosal flora in inflammatory bowel disease
A Swidsinski et al.
GASTROENTEROLOGY (2002)
Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice
M Schultz et al.
INFLAMMATORY BOWEL DISEASES (2002)
Probiotic bacteria enhance murine and human intestinal epithelial barrier function
K Madsen et al.
GASTROENTEROLOGY (2001)
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice
HC Rath et al.
INFECTION AND IMMUNITY (2001)
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
P Gionchetti et al.
GASTROENTEROLOGY (2000)
分享论文
